Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey Players

4 de junio de 2026 actualizado por: Daniel Muder, Dalarna County Council, Sweden

Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey Players: A Prospective Longitudinal Observational Cohort Study

This study examines how hand grip strength changes over the course of a competitive ice hockey season in elite male and female players.

Hand grip strength is a simple and widely used measure of upper-body strength and functional capacity. It is often used in sports science and clinical settings, but it is unclear whether grip strength remains stable throughout a season or changes depending on training load, match exposure, and fatigue.

In this study, elite ice hockey players from Swedish teams will have their grip strength measured at four timepoints during one season: pre-season, early season, mid-season, and late season. Both dominant and non-dominant hand strength will be assessed using a standardized dynamometer and protocol.

The main purpose is to determine how much grip strength varies within individual players over time and whether a single measurement can be considered representative of a player's true strength level across a season. The study will also evaluate the reliability of grip strength measurements and whether observed changes are large enough to be meaningful in a clinical or performance context.

No intervention is performed, and all measurements are non-invasive and conducted as part of routine testing environments within participating teams.

Descripción general del estudio

Estado

Aún no reclutando

Descripción detallada

This is a prospective longitudinal observational cohort study designed to evaluate within-season variability and measurement stability of maximal isometric hand grip strength in elite ice hockey players.

Hand grip strength is widely used as a surrogate marker of upper-limb strength and general neuromuscular capacity. Although its reliability has been well described in clinical and general athletic populations when measured using standardized protocols, limited evidence exists regarding its temporal stability in elite collision sport athletes over an entire competitive season. In particular, it remains unclear whether grip strength behaves as a stable individual characteristic or whether it is influenced by seasonal training load, match congestion, fatigue, or adaptation effects.

The study will include elite male and female ice hockey players recruited from Swedish top-level teams. Participants will undergo repeated standardized grip strength assessments at four predefined timepoints across one competitive season: pre-season baseline, early mid-season, late mid-season, and pre-playoff/end-of-season phase. All measurements will be performed using a calibrated hand dynamometer following a standardized protocol based on established clinical measurement guidelines, including consistent body positioning, handle adjustment, and repeated maximal trials for both dominant and non-dominant hands. Mean values from repeated trials will be used for analysis.

To reduce measurement variability, all testing will be conducted by trained assessors using harmonized instructions across participating teams. Where possible, testing sessions will be scheduled to minimize acute fatigue effects by ensuring a standardized recovery period following matches or high-intensity training sessions.

The primary analytical focus is within-subject variability of grip strength across the season, quantified using measures of dispersion and reliability, including coefficient of variation (CV%), within-subject standard deviation, and intraclass correlation coefficients (ICC). Additional analyses will estimate measurement error (standard error of measurement) and minimal detectable change (MDC95) to determine the smallest meaningful change in grip strength that exceeds expected measurement noise.

Longitudinal changes in grip strength across the season will be assessed using mixed-effects statistical models to account for repeated measures within individuals and potential group-level effects such as sex and playing level.

The study does not involve any interventions, treatment allocation, or experimental manipulation. All assessments are non-invasive and conducted within routine team environments. The findings are intended to inform interpretation of grip strength in athletic monitoring, rehabilitation contexts, and performance evaluation, specifically whether single timepoint measurements can be reliably used for comparison against normative data or whether seasonality must be considered in clinical and performance decision-making.

Tipo de estudio

De observación

Inscripción (Estimado)

150

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Daniel Muder, MD, PhD
  • Número de teléfono: +46722027596
  • Correo electrónico: danielmuder@email.com

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Dalarna County
      • Falun, Dalarna County, Suecia, 79182
        • Center for Clinical Research Dalarna, Uppsala University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

150

Descripción

Inclusion Criteria:

  • Contracted elite ice hockey players in participating Swedish teams (SHL, HockeyAllsvenskan, SDHL or equivalent top division)
  • Male or female players competing at elite level
  • Available for testing at all predefined measurement timepoints across the season
  • Able to perform maximal hand grip strength testing
  • Provides informed consent

Exclusion Criteria:

  • Acute hand or wrist injury at baseline preventing maximal grip strength testing
  • Any condition during the study period preventing completion of repeated grip strength assessments
  • Inability to participate in all scheduled measurement sessions
  • Refusal to participate

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Elite Ice Hockey Players Cohort
Elite male and female ice hockey players from Swedish top-level teams (SHL, HockeyAllsvenskan, SDHL). Participants undergo repeated standardized measurements of hand grip strength across four predefined timepoints during one competitive season (pre-season, early season, mid-season, and pre-playoff/end-of-season). The same individuals are followed longitudinally to assess within-subject variability and stability of grip strength over time.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Within-Subject Variability of Hand Grip Strength
Periodo de tiempo: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Within-subject variability of maximal isometric hand grip strength across a competitive season in elite ice hockey players, expressed as coefficient of variation (CV%) across repeated measurements.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Test-Retest Reliability of Hand Grip Strength
Periodo de tiempo: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Reliability of repeated grip strength measurements across the season assessed using intraclass correlation coefficient (ICC).
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Within-Subject Standard Deviation of Grip Strength
Periodo de tiempo: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Absolute within-player variability in grip strength across the competitive season.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Standard Error of Measurement (SEM)
Periodo de tiempo: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Measurement error of grip strength across repeated seasonal assessments.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Minimal Detectable Change (MDC95)
Periodo de tiempo: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Smallest change in grip strength considered beyond measurement error with 95% confidence.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Seasonal Change in Grip Strength
Periodo de tiempo: From baseline (pre-season) to end of season (pre-playoff), up to 8 months
Systematic changes in maximal grip strength across the competitive season assessed using longitudinal mixed-effects models.
From baseline (pre-season) to end of season (pre-playoff), up to 8 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de septiembre de 2026

Finalización primaria (Estimado)

30 de abril de 2027

Finalización del estudio (Estimado)

31 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

30 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de abril de 2026

Publicado por primera vez (Actual)

6 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

5 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

4 de junio de 2026

Última verificación

1 de abril de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • EPM 2026-03226-01

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

Descripción del plan IPD

Any data shared with colleagues or collaborating researchers will be fully anonymized or pseudonymized to protect participant privacy in accordance with GDPR regulations. Data transfers will occur under strict confidentiality agreements, and all parties will adhere to applicable data protection laws to ensure the security and privacy of personal information. We will act in accordance with the ethical approval granted by the Swedish Ethical Review Authority (EPM) and comply with all relevant local policies regarding data protection.

Marco de tiempo para compartir IPD

From the publication of the protocol and for 10 years thereafter.

Criterios de acceso compartido de IPD

Access to individual participant data is typically restricted to authorized researchers involved in the study or approved collaborators under strict confidentiality and data protection agreements.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir